A comprehensive view of Metabolic Disorders. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Government & Public Policy Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Eli Lilly partners with biotech Nimbus Therapeutics to develop novel targeted therapies for metabolic diseases; Nimbus to use its computational drug discovery engine and Lily to assume development, global commercialization activities
Published: October 12, 2022 by SeeNews Pharmaceuticals
Amgen opens new 245,000 square-foot, nine-story R&D facility in San Francisco, California, with staff of 650; new facility to focus on discovering cancer, inflammatory disease, cardiometabolic disorder therapies
Published: October 07, 2022 by PR Newswire
Fitch upgrades Sanofi's outlook to positive from stable, reflecting its transition toward innovative pharmaceutical company and vaccine producer, away from cardio-metabolic leader with rare disease franchise, broad portfolio of legacy off-patent drugs
Published: May 24, 2022 by ENP Newswire
Abbott releasing 12 metabolic nutrition formulas previously on hold free of charge to patients; products were on hold following recall of some powdered infant formulas, with product manufacturing to resume at Sturgis, Michigan, plant pending FDA approval
Published: May 02, 2022 by Abbott Laboratories
Resistant starches found to enrich beneficial gut microbes, helping to reduce fat, regulate blood glucose metabolism and insulin levels, protect gut; researchers conclude that resistant starches can be applied to produce functional foods for gut health
Published: April 05, 2022 by Food Chemistry

Ask us about our Government & Public Policy market view

Trending Chart

Interactive chart with headline count